IL6 and metabolic syndrome: Metabolic syndrome (MetS), characterized by a cluster of metabolic dysregulations, such as abdominal obesity, hypertension, hyperglycemia, and dyslipidemia, leads to systemic low-grade inflammation primarily through the increased production of proinflammatory cytokines, such as IL-6, CRP, and TNF-α [9].